This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Aktis Oncology Inc AKTS
$24.11
โฒ +2.46%
(+$0.58)
Open
$24.42
Prev Close
$23.53
Day Range
$23.38 โ $24.83
52W Range
$14.72 โ $29.16
Market Cap
$1.33B
Beta
148.48
EPS (TTM)
$-1.64
๐ Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2026-01-09 |
| Shares Out. | 53,400,000 |
| Website | aktisoncology.com/ โ |
| Phone | 13026587581 |
Aktis Oncology Inc is a publicly traded company under the ticker symbol AKTS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
12 analysts (2026-06-01)
๐ฐ Latest News for AKTS
Raymond James Initiates Coverage On Aktis Oncology with Strong Buy Rating, Announces Price Target of $40
Aktis Oncology, Inc. (AKTS) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday
Aktis Oncology: Mini-Proteins With A Targeted Punch
